跳至主要内容
临床试验/NCT02110277
NCT02110277终止不适用

Photoacoustic Imaging of the Ovary

UConn Health2 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2014年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
2
试验地点
2
主要终点
To Measure Photoacoustic Imaging (PAI)/Ultrasound Signature From Ovaries Prior to Surgery Using the Ratio of Deoxy/Oxy Hb

研究概览

简要总结

The purpose of this study is to develop technology to image the ovaries in order to better evaluate ovarian disease and to study how these experimental imaging techniques might work together or separately to improve our ability to detect ovarian cancer.

详细描述

Epithelial ovarian cancer causes the highest mortality of any of the gynecologic cancers although it is the second most common gynecologic malignancy. Ovarian cancer is not usually detected earlier than Stage III or IV because it is usually asymptomatic; yet survival is high with early stage disease. In addition, women with a pelvic mass noted on ultrasound that undergo oophorectomy have only a 1-3% risk of malignancy and thus 97-99% will be overtreated because of our inability to reliably differentiate benign from malignant masses with ultrasound. BRCA1 testing and family history will identify certain high-risk individuals who have a higher risk of malignancy and need a modality that will be more reliable in detecting early cancers to provide more accurate surveillance.We are developing a new transvaginal imaging device optimized for ovarian cancer detection, diagnosis and validated from ex vivo and in vivo clinical studies. This automated system may provide an early diagnostic tool for ovarian cancer in the future.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • All patients, twenty one years or older, referred to the University of Connecticut for conditions necessitating oophorectomy.
  • Patients cannot be pregnant or wish to become pregnant.
  • Willingness to participate in the study.

排除标准

  • All Subjects who fail to meet the inclusion criteria are ineligible for the study.

研究组 & 干预措施

PAI/ultrasound Diagnostic Group

Experimental

These patients will include women who are at risk for ovarian cancer and wish to undergo prophylactic oophorectomy, or who have an ovarian mass suggestive of a malignancy and are counseled to undergo oophorectomy.

干预措施: PAI/ultrasound Diagnostic Group (Device)

结局指标

主要结局

To Measure Photoacoustic Imaging (PAI)/Ultrasound Signature From Ovaries Prior to Surgery Using the Ratio of Deoxy/Oxy Hb

时间窗: 5 years

To develop a method of analyzing PAI ovarian tissue images measuring oxy and deoxy hemoglobin as well as the ratio of deoxy/oxy Hb to recognize the presence of ovarian abnormalities and compare changes seen with ultrasound to changes seen with PAI.

次要结局

  • Pathologic Diagnosis and in Vivo Imaging(5 years)

研究者

发起方
UConn Health
申办方类型
Other
责任方
Principal Investigator
主要研究者

Molly Brewer

Professor, Obstetrics and Gynecology

UConn Health

研究点 (2)

Loading locations...

相似试验

Photoacoustic Imaging of the Ovary | 临床试验